Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.82 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.82 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238048 | 1.00 | MEN1 (1.00) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| SCHEMBL5213348 | 0.93 | MEN1 (0.88) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| SCHEMBL3490486 | 0.93 | MEN1 (0.86) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| Potassium SCHEMBL3490489 | 0.93 | MEN1 (0.86) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| SCHEMBL3489772 | 0.90 | PTGER4 (1.00) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| SCHEMBL9565889 | 0.89 | AGTR1 (0.83) | AGTR1 | |
| L-159913 SCHEMBL9144158 | 0.88 | AGTR1 (1.00) | AGTR1 | |
| SCHEMBL9565941 | 0.88 | AGTR1 (0.86) | PTGER4PTGER3AGTR1 | |
| SCHEMBL29433721 | 0.88 | PTGER4 (0.82) | MEN1KMT2APTGER4PTGER3AGTR1 | |
| SCHEMBL9566072 | 0.88 | PTGER4 (0.82) | MEN1KMT2APTGER4PTGER3AGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279353-A1 | METHODS TO ENHANCE DELIVERY AND ENGRAFTMENT OF STEM CELLS INCLUDING THE IDENTIFICATION OF SPECIFIC PROSTAGANDIN E2 RECEPTORS | UNIV INDIANA RES & TECH CORP (US) | 2023-09-07 | — | — | US | claimed |
| US-11459545-B2 | Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2022-10-04 | — | — | US | claimed |
| US-20250333702-A1 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-30 | — | — | US | disclosed |
| US-20250101381-A1 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-03-27 | — | — | US | disclosed |
| US-20230279353-A1 | METHODS TO ENHANCE DELIVERY AND ENGRAFTMENT OF STEM CELLS INCLUDING THE IDENTIFICATION OF SPECIFIC PROSTAGANDIN E2 RECEPTORS | UNIV INDIANA RES & TECH CORP (US) | 2023-09-07 | — | — | US | disclosed |
| US-20230002733-A1 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
| US-11459545-B2 | Methods to enhance delivery and engraftment of stem cells including the identification of specific prostaglandin E2 receptors | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2022-10-04 | — | — | US | disclosed |
| US-20220118021-A1 | ENHANCED STEM CELL COMPOSITION | FATE THERAPEUTICS INC (US) | 2022-04-21 | — | — | US | disclosed |
| US-20220054553-A1 | METHODS OF TREATING ISCHEMIA | FATE THERAPEUTICS INC (US) | 2022-02-24 | — | — | US | disclosed |